OTC Market Forces Impact Industry Growth

Internal and External OTC Market Forces Impact Industry Growth

The U.S. OTC market overall experienced 2.0% growth in 2017 with upper respiratory and topical products classes posting higher than average gains, according to Kline’s Nonprescription Drugs USA 2017 annual market study. “A strong cold and flu season in both Q1 and Q4 of 2017 drove the OTC cold and sinus market up 4.5% from 2016 levels,” says Laura Mahecha, Industry Manager for Kline’s Healthcare Practice. The topical products class posted 3.6% growth in 2017, driven by strong gains for OTC topical analgesics.Continue reading

Nonprescription Drugs USA

A Multitude of Upper Respiratory Choices Creates Confusion Among Consumers

The upper respiratory self care market is crowded with many brands, ingredients, claims, and offers. Walking down the cold and allergy aisles of retail stores can make consumers dizzy from the assortment and sheer number of products on shelves, each making similar but not exactly the same claims. This makes the cold and allergy aisle a complex section for consumers to navigate. Much of this complexity is rooted in the fact that colds, the flu, and allergies all affect the upper respiratory system—yet each condition has symptoms that set it apart, as well as symptoms that overlap with each other. Continue reading